Early kinetics of C-reactive protein predicts oncological outcome of patients with metastatic renal cell carcinoma under first-line therapy with immune checkpoint inhibitors

被引：0

作者：

Schuettke, V ^{[1
]}

Kusiek, C. ^{[1
]}

Mehralivand, S. ^{[1
]}

Buerk, B. T. ^{[1
]}

Thomas, C. ^{[1
]}

Fuessel, S. ^{[1
]}

Erdmann, K. ^{[1
]}

机构：

[1] Tech Univ Dresden, Dept Urol, Dresden, Germany

来源：

EUROPEAN UROLOGY | 2023年 / 83卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A1031

引用

页数：1

共 50 条

[41] The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients [J].

Shengjie Guo ;

Xiaobo He ;

Qian Chen ;

Guangwei Yang ;

Kai Yao ;

Pei Dong ;

Yunlin Ye ;

Dong Chen ;

Zhiling Zhang ;

Zike Qin ;

Zhuowei Liu ;

Yunfei Xue ;

Meng Zhang ;

Ruiwu Liu ;

Fangjian Zhou ;

Hui Han .

BMC Cancer, 17

[42] Beyond First-Line Immune Checkpoint Inhibitor Therapy in Patients With Hepatocellular Carcinoma [J].

Sharma, Rohini ;

Aval, Leila Motedayen .

FRONTIERS IN IMMUNOLOGY, 2021, 12

[43] C-reactive protein kinetics as a predictive marker for long-term outcome of immune checkpoint inhibitors in oesophagogastric cancer [J].

Yohei Nose ;

Takuro Saito ;

Yukinori Kurokawa ;

Tsuyoshi Takahashi ;

Kazuyoshi Yamamoto ;

Kota Momose ;

Kotaro Yamashita ;

Koji Tanaka ;

Tomoki Makino ;

Hidetoshi Eguchi ;

Yuichiro Doki ;

Hisashi Wada .

BJC Reports, 1 (1)

[44] Immune checkpoint inhibitors for first-line treatment of advanced esophageal squamous cell carcinoma [J].

Alsina, Maria ;

Fleitas-Kanonnikoff, Tania .

MED, 2024, 5 (09) :1038-1040

[45] C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis [J].

Zhou, Wei ;

Zhang, Guang-lin .

PLOS ONE, 2019, 14 (10)

[46] Preoperative C-reactive protein/albumin ratio predicts outcome of surgical papillary renal cell carcinoma [J].

Gao, Jie ;

Agizamhan, Sezim ;

Zhao, Xiaozhi ;

Jiang, Bo ;

Qin, Haixiang ;

Chen, Mengxia ;

Guo, Hongqian .

FUTURE ONCOLOGY, 2019, 15 (13) :1459-1468

[47] Second-Line VEGFR TKI Outcomes After First-Line Immune Checkpoint Blockade in Metastatic Renal Cell Carcinoma [J].

不详 .

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (12) :10-11

[48] Primary resistance (PrR) versus acquired resistance (AcR) to immune checkpoint inhibitors (ICI) in first-line metastatic renal cell carcinoma (mRCC) [J].

Guida, A. ;

Silva, C. Alves Costa ;

Colomba-Blameble, E. ;

Flippot, R. ;

Salviat, F. ;

Bracarda, S. ;

Escudier, B. ;

Albiges, L. .

ANNALS OF ONCOLOGY, 2020, 31 :S570-S570

[49] Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors [J].

Yasuda, Yosuke ;

Saito, Kazutaka ;

Yuasa, Takeshi ;

Kitsukawa, Shinichi ;

Urakami, Shinji ;

Yamamoto, Shinya ;

Yonese, Junji ;

Takahashi, Shunji ;

Fukui, Iwao .

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (05) :884-889

[50] Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors [J].

Yosuke Yasuda ;

Kazutaka Saito ;

Takeshi Yuasa ;

Shinichi Kitsukawa ;

Shinji Urakami ;

Shinya Yamamoto ;

Junji Yonese ;

Shunji Takahashi ;

Iwao Fukui .

International Journal of Clinical Oncology, 2013, 18 :884-889

← 1 2 3 4 5 →